As the resistance rate at baseline was low, no conclusion could be made about clarithromycin's efficacy for infections caused by macrolide-resistant S. pneumoniae. Both treatments were well tolerated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback